6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblastsAimilia D. Sklirou, Ioannis P. Trougakos|Scientific Reports|2017Cited by 66
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health WorkersEvangelos Terpos, Meletios Α. Dimopoulos, Sentiljana Gumeni et al.|Cells|2021Cited by 46
Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA TherapyIoannis Ntanasis‐Stathopoulos, Evangelos Terpos, Vangelis Karalis et al.|HemaSphere|2022Cited by 44